Literature DB >> 20346697

Genetic reference materials and their application to haematology.

J R Hawkins1, M Hawkins, J Boyle, E Gray, P Matejtschuk, P Metcalfe.   

Abstract

Genetic investigations are becoming increasingly useful and widespread in many areas of human health. However, there is a worldwide lack of certified reference materials for use in genetic testing, meaning that tests are being run without well validated controls and new assays are more difficult to develop and validate. We have responded to this challenge by starting a programme of developing genetic reference materials (GRMs) for international accreditation and worldwide distribution. Our approach has been to make materials for disorders where testing is commonplace and genotyping errors have been demonstrated. To ensure a continuing supply of DNA, cell lines are established from consenting, phenotypically well-characterised patients and are then grown up in bulk for genomic DNA extraction to yield up to 100 milligrams of DNA. In most cases the DNA is then formulated, freeze-dried and sealed in glass ampoules to ensure greater stability over time and obviate the need for chilled transportation. In this paper we explore the options and routes available to the production of DNA reference materials and describe the establishment of the first internationally recognised reference materials for human genomic DNA, with particular reference to some genetic tests carried out frequently within haematological and cardiovascular laboratories. 2010. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20346697     DOI: 10.1016/j.biologicals.2010.02.004

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  2 in total

1.  Establishment of the first WHO international genetic reference panel for Prader Willi and Angelman syndromes.

Authors:  Jennifer Boyle; Malcolm Hawkins; David E Barton; Karen Meaney; Miriam Guitart; Anna O'Grady; Simon Tobi; Simon C Ramsden; Rob Elles; Elaine Gray; Paul Metcalfe; J Ross Hawkins
Journal:  Eur J Hum Genet       Date:  2011-05-18       Impact factor: 4.246

2.  Utilizing CRISPR/Cas9 technology to prepare lymphoblastoid cell lines harboring genetic mutations for generating quality control materials in genetic testing.

Authors:  Li Zhou; Rui Li; Runling Zhang; Rongxue Peng; Kun Chen; Peng Gao; Jiawei Zhang; Rui Zhang; Jinming Li
Journal:  J Clin Lab Anal       Date:  2020-03-02       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.